InterVenn BioSciences lands $9.4 mln

Redwood City, California-based InterVenn BioSciences, a developer of an AI-driven mass spectrometry platform, has raised $9.4 million in funding. Genoa Ventures led the round with participation from True Ventures, Amplify Partners, Boost VC and Prado SV.

12 December 2018•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail